Cowealth Medical China Co (SHSE:603122) FFO


SHSE:603122 Cowealth Medical China Co Ltd SHSE:603122
41 GF Score
Price ¥11.48
GF Value ¥3.88
Valuation Significantly Overvalued
! 3 Warning Signs
View Full Analysis

What is Cowealth Medical China Co FFO?

FFO (Funds from operations) only applies to REITs.

SHSE:603122
41GF Score
Cowealth Medical China Co Ltd SHSE:603122
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Cowealth Medical China Co (SHSE:603122) Overvalued in 2026?

Based on GuruFocus' analysis, Cowealth Medical China Co stock appears to be overvalued. The current stock price of ¥11.48 is trading 195.9% above its estimated GF Value™ of ¥3.88. GuruFocus considers Cowealth Medical China Co to be Significantly Overvalued.

Key valuation signals for SHSE:603122:

  • FFO:
  • GF Value™: ¥3.88 vs. price of ¥11.48 (195.9% above fair value)
  • GF Score™: 41/100 with 3 warning signs

No single metric tells the full story. See the SHSE:603122 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Cowealth Medical China Co Business Description

Address No. 1001 Qinzhou North Road, 21st Floor, Building 12, Xuhui District, Shanghai, CHN, 200131
Cowealth Medical China Co Ltd operates as a diagnostic clinical laboratory company. It has introduced radiation oncology technology into the market.
41GF Score

Get the complete analysis for SHSE:603122

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥11.48
Price
¥3.88
GF Value